USD 2.44 billion
Seborrheic Dermatitis Treatment Market Size, Share, Growth Analysis, By Dosage Form(Shampoo, Cream, Ointment, Tablet), By Treatment(Anti-Fungal, Antibiotics, Anti Inflammatory, and Others), By Type(Prescription Based Drugs, and Over the Counter Drugs), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2239 |
Region:
Global |
Published Date: April, 2024
Pages:
217
|Tables:
92
|Figures:
72
Seborrheic Dermatitis Treatment Market Insights
Global Seborrheic Dermatitis Treatment Market size was valued at USD 2.44 billion in 2022 and is poised to grow from USD 2.72 billion in 2023 and to USD 5.67 billion by 2031, growing at a CAGR of 11.1% in the forecast period (2024-2031).
Advances in technology within the healthcare sector, a rise in autoimmune disorders like psoriasis and HIV, and an increase in research activities are the main factors driving the growth of the global market share for treatments for seborrheic dermatitis. The seborrheic dermatitis treatment market is expected to develop due to an increase in dermatological clinics and a rise in the number of available treatment options. For example, there are several types of shampoos, lotions, gels, and foams on the market that can be used to treat seborrheic dermatitis. Doctors recommend medicated shampoos as a first line of treatment to assist reduce discomfort and manage flaking. Over-the-counter (OTC) choices abound at your neighborhood pharmacy and online. shampoos with antifungal ingredients such as selenium sulphide.
The industry that produces devices for treating seborrheic dermatitis is adopting crucial strategies like cooperation, acquisition, agreement, and partnership, which is driving the market's expansion. Furthermore, since society is becoming more interested in self-care and personality development, dermatology is one of the top medical specialties in the world. The main prerequisite for advancement in this industry is market expansion and R&D growth to meet patient needs and offer high-quality services and solutions. Numerous new methods are being developed, such as UV therapy to treat various derma concerns, software to identify skin conditions, and skin protection measures. This boosts consumer demand for derma treatments and propels the market for therapies for seborrheic dermatitis.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Anti Fungal
Fastest Growth
Antibiotics
Growth Rate
11.1% CAGR
Global Seborrheic Dermatitis Treatment Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Seborrheic Dermatitis Treatment Market Segmental Analysis
The global seborrheic dermatitis treatment market is segmented based on dosage form, treatment, type and regional. In terms of dosage, the market is segmented into shampoo, cream, ointment, tablet and others. Based on treatment, the market is bifurcated into anti-fungal, antibiotics, anti-inflammatory and others. Based on type, the market is bifurcated into prescription-based drugs and over the counter drugs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The treatment category is expanding in market share due to growing disposable incomes and established local businesses in the area.
Analysis by Treatment
As per categorization by treatment, the market is classified into anti-fungal, antibiotics, anti-inflammatory and others. Among these, anti-fungal earned the largest share and continues to dominate the market. The development of more precise and effective antifungal and antibiotic therapies is the focus of innovations in the global market for seborrheic dermatitis treatments. Novel formulations with better delivery systems, like foams, shampoos, and lotions, are among these advancements that increase patient adherence and results. Furthermore, there is a growing movement in personalized medicine that uses genetic information to customize care. By reducing side effects and addressing the multifactorial character of seborrheic dermatitis, these developments hope to increase patient satisfaction and treatment efficacy.
Due to its capacity to address the underlying inflammation linked to the ailment, the anti-inflammatory segment of the global market for treatments for seborrheic dermatitis is anticipated to grow at the quickest rate. Since inflammatory responses are a hallmark of seborrheic dermatitis, anti-inflammatory medications provide important therapeutic advantages by lowering scaling, redness, and itching. Furthermore, the market's demand for anti-inflammatory medicines is being driven by developments in topical corticosteroids, calcineurin inhibitors, and new biologic drugs, which present potential therapy alternatives with enhanced safety profiles.
Analysis by Distribution Channel
The goal of new developments in cream and ointment formulations for the global market for the treatment of seborrheic dermatitis is to improve patient convenience and efficacy. Combination therapies that combine antifungals, moisturizers, and anti-inflammatory drugs have been developed recently, offering complete therapy regimens. In addition, there is an increasing focus on using natural substances that have been shown to have therapeutic advantages to satisfy consumer desires for softer skincare products. Furthering the use of creams and ointments in the treatment of seborrheic dermatitis, formulation technology advances seek to enhance drug delivery and skin penetration, optimizing therapeutic outcomes while minimizing side effects.
As they are convenient and effective, shampoo and tablets are expected to increase at the quickest rate in the global market for seborrheic dermatitis treatments. Shampoos address the underlying cause of seborrheic dermatitis, such as excessive yeast production, and provide direct application to affected areas of the scalp. In addition, the creation of medicated shampoos with antifungal and anti-inflammatory ingredients offers a wide range of treatment alternatives, which appeals to customers looking for effectiveness and ease. In a similar vein, tablets provide systemic therapy by targeting fungal overgrowth and inflammation from the inside out, offering potentially effective treatment options for seborrheic dermatitis management.
Global Seborrheic Dermatitis Treatment By Treatment (%)
To get detailed analysis on other segments, Request For Free Sample Report
Seborrheic Dermatitis Treatment Market Regional Insights
The market for treatments for seborrheic dermatitis in North America is anticipated to expand throughout the course of the forecast period due to factors such as the rise in autoimmune illnesses including psoriasis and HIV, advancements in healthcare technology, and a well-established healthcare system. To expand their product offerings for skin care, a significant number of businesses are implementing business methods like cooperation, acquisition, partnership, agreement, and business expansion. Due to growing public knowledge of seborrheic dermatitis and growing youth awareness of physical appearance, Asia-Pacific is predicted to grow during the projected period. Moreover, throughout the projection period, it is expected that the expansion of the seborrheic dermatitis market in Asia-Pacific will be driven by increases in disposable income, the number of dermatological clinics, and the number of specialists who treat dermatological illnesses.
The Middle East and Africa (MEA), Europe, and Latin America are the major contributors to the global behavioral health software market's quick expansion. In Europe, the market is expanding due to government measures supporting digital health solutions and raising awareness of mental health issues. Growth in Latin America is being driven by increased investments in healthcare infrastructure and increased awareness of mental health issues. In the meantime, the MEA region sees faster adoption because of initiatives to incorporate technology into healthcare systems and a rising understanding of the significance of mental health, which is fueling the market for behavioral health software in these areas to rise rapidly.
Global Seborrheic Dermatitis Treatment By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Seborrheic Dermatitis Treatment Market Dynamics
Drivers
Increasing Investment in Seborrheic Dermatitis Treatment Infrastructure
- The increasing cost of healthcare, which contributes to the development of the industry's infrastructure, is another important factor driving the seborrheic dermatitis market's growth rate. Additionally, by boosting funding, several government organisations hope to strengthen the healthcare infrastructure, which would further alter the dynamics of the market.
Formulative Advances by Many Companies
- Research and development efforts are increasing, which is driving the market's growth. This will present advantageous prospects for the expansion of the seborrheic dermatitis market. In addition, an increase in drug launches and approvals will accelerate the market's growth rate. Increasing funding for the creation of cutting-edge technologies and the expansion of emerging markets will both present favourable prospects for the growth of the seborrheic dermatitis market throughout the projected timeframe.
Restraints
New Regulation Posing Limitations
- The high expense of the treatment will hinder the market's rate of growth. A lack of infrastructure for healthcare and a shortage of primary care services in emerging nations will provide challenges to the market for seborrheic dermatitis. Furthermore, during the projection period of 2022–2029, stringent regulatory rules and a lack of public awareness would limit and further hinder the market's growth pace.
Reimbursement Challenges
- The difficulty of reimbursement is one major barrier affecting the global market for treatments for seborrheic dermatitis. Even though there are many different treatment choices available, different locations may have varied coverage and reimbursement policies for these therapies. Patients seeking efficient care may find it difficult to access this discrepancy, especially in areas with low reimbursement rates or restricted healthcare coverage. As a result, patients might have to deal with limited treatment alternatives or expensive difficulties, which would impede market expansion and make it more difficult to manage seborrheic dermatitis.
Request Free Customization of this report to help us to meet your business objectives.
Seborrheic Dermatitis Treatment Market Competitive Landscape
The leading companies in the market for treatments for seborrheic dermatitis are Almirall S.A., Aurobindo Pharma Ltd., Bausch Health Companies Inc., D3 Development, Inc., F. Hoffman-La Roche AG, GlaxoSmithKline plc., Leo Pharma A/S, Lupin Limited, Medimetriks Pharmaceutical Inc., and Sun Pharmaceutical Industries Ltd. The competitive analysis and profiles of these companies are provided. Aurobindo Pharma and other major competitors are present in the industry. To enhance the product portfolio of the seborrheic dermatitis treatment market, major companies have embraced new launch, product growth, and acquisition as critical developmental methods.
Top Player’s Company Profiles
- Johnson & Johnson Private Limited (US)
- Novartis AG (Switzerland)
- Bausch Health Companies Inc. (Canada)
- Allergan (Ireland)
- Bayer AG (Germany)
- Lupin (India)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Hikma Pharmaceuticals PLC (UK)
- Sanofi (France)
- Merck KGaA (Germany)
- Merck & Co., Inc. (US)
- Aurobindo Pharma (India)
- LEO Pharma A/S (Denmark)
- AstraZeneca (UK)
- Pfizer Inc. (US)
- Abbott (US)
Recent Developments
- In June 2022, A novel topical corticosteroid cream approved by the FDA for the treatment of seborrheic dermatitis was announced by Pfizer. With its strong corticosteroid and improved skin penetration properties, the cream meets the unmet demands of patients with moderate to severe forms of illness by providing quick symptom alleviation and long-lasting efficacy.
- In August 2022, Novartis unveiled a novel oral drug for the treatment of seborrheic dermatitis. This tablet offers a systemic approach to treating the underlying causes of the ailment by combining its antifungal and anti-inflammatory characteristics. For patients with broad or resistant seborrheic dermatitis, the easy-to-take oral formulation offers an alternate course of treatment that improves therapeutic results and patient adherence.
- In October 2023, A new medicated shampoo developed especially for the treatment of seborrheic dermatitis was introduced by Johnson & Johnson. The shampoo effectively relieves symptoms like flaking and itching while boosting the health of the scalp thanks to its blend of antifungal and anti-inflammatory chemicals.
Seborrheic Dermatitis Treatment Key Market Trends
- Advancements Within Topical Treatments: The focus on topical treatments that address the underlying causes of seborrheic dermatitis is one important trend. Pharmaceutical companies are making investments in the creation of novel topical formulations, such as creams, shampoos, and foams, with chemicals including keratolytic, corticosteroids, and antifungal agents, as the market changes. These formulations are designed to help people with seborrheic dermatitis, a persistent skin condition, by addressing the inflammation and yeast overgrowth that are linked to the condition.
- Preference for Medicated Shampoos: Additionally, the use of medicated shampoos as the first line of treatment for scalp-related seborrheic dermatitis is surging in the market. As medicated shampoos effectively reduce flaking, redness, and itching associated with scalp involvement, they are becoming more and more popular. Active components in medicated shampoos include coal tar, zinc pyrithione, and ketoconazole. Medication shampoos are widely used to treat seborrheic dermatitis as they are convenient to incorporate into daily hair care practices.
Seborrheic Dermatitis Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the infrastructure for treating seborrheic dermatitis is being invested in due to growing healthcare expenditures. This is being further supported by increased funding from government agencies, which is changing the dynamics of the market. In addition, increased investment in cutting-edge technology and the penetration of emerging countries, along with a spike in medication approvals and launches, are propelling the market's growth and offering encouraging prospects for progress. The global market for treatments for seborrheic dermatitis is growing, but it is constrained by strict regulations, low public awareness, difficulties with reimbursement, and differences in healthcare coverage. These factors make it difficult for patients to receive effective care and prevent the market from expanding.
The market for treatments for seborrheic dermatitis is dominated by large companies like Almirall S.A., Aurobindo Pharma Ltd., and others. These companies use tactics including acquisitions, growth, and the introduction of new products to diversify their product lines and stay competitive. To address the underlying causes of seborrheic dermatitis, pharmaceutical companies are concentrating on creating novel topical formulations, such as creams and shampoos that contain keratolytic, corticosteroids, and antifungal agents. Meanwhile, medicated shampoos, which contain active ingredients like coal tar and ketoconazole, are becoming more and more popular as the first-line treatment for cases related to the scalp as they effectively reduce symptoms like flaking, redness, and itching.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.44 billion |
| Market size value in 2031 | USD 5.67 billion |
| Growth Rate | 11.1% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Seborrheic Dermatitis Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Seborrheic Dermatitis Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Seborrheic Dermatitis Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Seborrheic Dermatitis Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Seborrheic Dermatitis Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Seborrheic Dermatitis Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
